Cargando…

Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response

A major limiting factor retarding the clinical success of dendritic cell (DC)-based genetic immunizations (DNA vaccination) is the scarcity of biologically safe and effective carrier systems for targeting the antigen-encoded DNA vaccines to DCs under in vivo settings. Herein, we report on a potent,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garu, Arup, Moku, Gopikrishna, Gulla, Suresh Kumar, Chaudhuri, Arabinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817821/ https://www.ncbi.nlm.nih.gov/pubmed/26666450 http://dx.doi.org/10.1038/mt.2015.215

Ejemplares similares

Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity
por: Cervantes-Barragan, Luisa, et al.
Publicado: (2010)

Role of dendritic cells in the regulation of antitumor immunity
por: Wathelet, Nathalie, et al.
Publicado: (2013)

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
por: Cao, Jun, et al.
Publicado: (2013)

Uric acid enhances the antitumor immunity of dendritic cell-based vaccine
por: Wang, Yihan, et al.
Publicado: (2015)

Antitumor Immunity Induction by Intracellular Hyperthermia Using Magnetite Cationic Liposomes
por: Yanase, Mitsugu, et al.
Publicado: (1998)

Will vaccine immunity last?
por: Lawton, Graham
Publicado: (2020)

In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes
por: Zhang, Jun, et al.
Publicado: (2021)

Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model
por: Shimizu, Taro, et al.
Publicado: (2017)

DNA–Liposome Hybrid Carriers for Triggered Cargo Release
por: Baumann, Kevin N., et al.
Publicado: (2022)

Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013)

Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells
por: Markov, O. V., et al.
Publicado: (2016)

In vivo antitumor activity of liposome-plasmid DNA encoding mutant survivin-T34A in cervical cancer
por: Qiu, Fang, et al.
Publicado: (2018)

Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo
por: HORIUCHI, YUTAKA, et al.
Publicado: (2015)

Alocasia cucullata Exhibits Strong Antitumor Effect In Vivo by Activating Antitumor Immunity
por: Peng, Qiuxian, et al.
Publicado: (2013)

Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo
por: Li, Ni, et al.
Publicado: (2011)

Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy
por: Van Acker, Heleen H, et al.
Publicado: (2015)

Multimodality Imaging of Bone Marrow–Derived Dendritic Cell Migration and Antitumor Immunity()
por: Ahn, Su-Bi, et al.
Publicado: (2017)

Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity
por: Huang, Yingying, et al.
Publicado: (2017)

Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
por: Cancel, Jean-Charles, et al.
Publicado: (2019)

Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity
por: Wang, Zining, et al.
Publicado: (2021)

Development of Thermo- and pH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives
por: Ribeiro, Beatriz C., et al.
Publicado: (2022)

Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
por: Luput, Lavinia, et al.
Publicado: (2020)

Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice
por: Takayama, Takuma, et al.
Publicado: (2020)

Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
por: Ohshio, Yasuhiko, et al.
Publicado: (2015)

Differential antitumor immunity mediated by NKT cell subsets in vivo
por: Crowe, Nadine Y., et al.
Publicado: (2005)

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity
Publicado: (1996)

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
por: Lamberti, María Julia, et al.
Publicado: (2020)

P. aeruginosa Mediated Necroptosis in Mouse Tumor Cells Induces Long-Lasting Systemic Antitumor Immunity
por: Qi, Jia-long, et al.
Publicado: (2021)

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
por: Chuang, Chi-Mu, et al.
Publicado: (2010)

Au-CGKRK Nanoconjugates for Combating Cancer through T-Cell-Driven Therapeutic RNA Interference
por: Gulla, Suresh Kumar, et al.
Publicado: (2018)

DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
por: Akbari, Omid, et al.
Publicado: (1999)

Stochastic Simulation of Endemic Salmonella enterica Serovar Typhi: The Importance of Long Lasting Immunity and the Carrier State
por: Saul, Allan, et al.
Publicado: (2013)

DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques
por: Kulkarni, Viraj, et al.
Publicado: (2014)

The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity
por: Xiao, Yichuan, et al.
Publicado: (2017)

Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
por: Medina, Benjamin D., et al.
Publicado: (2019)

Small Particles, Big Effects: The Interplay Between Exosomes and Dendritic Cells in Antitumor Immunity and Immunotherapy
por: Benites, Bruno Deltreggia, et al.
Publicado: (2019)

Nuanced role for dendritic cell intrinsic IRE1 RNase in the regulation of antitumor adaptive immunity
por: Flores-Santibañez, Felipe, et al.
Publicado: (2023)

Purified Dendritic Cell-Tumor Fusion Hybrids Supplemented with Non-Adherent Dendritic Cells Fraction Are Superior Activators of Antitumor Immunity
por: Zhang, Yunfei, et al.
Publicado: (2014)

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity
por: Song, Wenru, et al.
Publicado: (1997)

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
por: Chiappinelli, Katherine B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65eagds6turl8fubf0eqlutrdl